Contents

No items found.

Optimal Homocysteine: Evidence Based Range for Healthy Homocysteine

No items found.
Table of contents

Homocysteine, an amino acid often overlooked in routine health screenings, plays a crucial role in cardiovascular health, brain function, and bone health. Despite its significance, conventional reference ranges for homocysteine are typically too lenient, potentially missing early indicators of health risks and accelerating diseases.

At Superpower, we've analyzed current scientific literature to define a more protective optimal range for homocysteine. Our evidence-based approach focuses on preemptive health management, detecting and addressing suboptimal levels before they manifest as clinical issues.

Key Points

  • "Normal" is not optimal: Conventional "normal" homocysteine ranges are too permissive. Even levels within this range can silently damage blood vessels, nerve cells, and bones, increasing risks for cardiovascular disease, decline in brain health, and brittle bones.
    • Conventional Range: 5-15 μmol/L
    • Optimal Range: 4 to 8 µmol/L
  • Powerful predictor of longevity: Studies show homocysteine levels above 12 μmol/L significantly increase all-cause mortality risk.
  • Target the cause: Maintaining homocysteine levels below 8 μmol/L may offer protection against chronic diseases by addressing common pathways of oxidative stress and inflammation that underlie many age-related conditions.

What is Homocysteine?

Homocysteine is an amino acid produced naturally in your body during the breakdown of methionine, another amino acid you get from protein-rich foods like meat, fish, and dairy products. Unlike some amino acids, homocysteine isn't obtained directly from the diet but is formed as part of normal metabolic processes.

Once homocysteine is formed, your body quickly converts it into other beneficial substances with the help of certain B vitamins—specifically vitamin B6, vitamin B12, and folate (vitamin B9). These vitamins act like helpers, ensuring that homocysteine doesn't build up in your bloodstream.

Homocysteine plays a role in several important bodily functions:

  • Cellular Health: It contributes to the production of proteins needed for cell growth and repair.
  • Antioxidant Production: It helps in creating glutathione, one of the body's most powerful antioxidants that protect your cells from damage.
  • Brain Function: It aids in the formation of neurotransmitters, the chemicals that transmit signals in your brain.

Under normal conditions, homocysteine levels remain low. However, if there's a deficiency in the necessary B vitamins or if the metabolic processes are disrupted, homocysteine can accumulate. Elevated levels can damage the lining of your blood vessels and nerves, increasing the risk of cardiovascular diseases, cognitive decline, and bone health issues.

Why should you care about Homocysteine?

Elevated homocysteine levels are becoming increasingly more common in the Western world with an estimated 141.5 million people at an increased risk of homocysteine-related disease. At Superpower, we recognise its importance in assessing cardiovascular, brain, and metabolic health, as well as its role in overall inflammation in the body.

Systemic Inflammation

Homocysteine contributes to systemic inflammation—a root cause of many chronic diseases. Elevated levels stimulate the production of pro-inflammatory proteins, which can worsen conditions like heart disease, diabetes, and autoimmune disorders [1].

On a cellular level, homocysteine increases molecules that make white blood cells stick to and penetrate the walls of your blood vessels [2,3]. This process is crucial in the development of atherosclerosis, where fatty plaques build up in arteries. Homocysteine also promotes oxidative stress by increasing harmful free radicals, damaging the cells lining your blood vessels [4, 5].

This chronic, low-grade inflammation can contribute to neurodegenerative disorders like Alzheimer's disease, metabolic syndrome, and cardiovascular disease [6, 7]. It may also exacerbate autoimmune conditions and weaken your overall immune function [8].

Cardiovascular Health

Homocysteine in the blood has emerged as a significant independent risk factor for cardiovascular disease [9 - 11]. It directly contributes to the formation of atherosclerotic plaques—fatty deposits in the arteries that can lead to heart attacks and strokes [9-11]. Homocysteine is also directly involved in vascular remodelling, leading to increased arterial stiffness – a key factor in cardiovascular health [12 - 14].

At the cellular level, homocysteine enhances oxidative stress and inflammation in the endothelial cells that line your blood vessels. It reduces the production of nitric oxide, a potent molecule essential for blood vessels to relax and dilate properly [7, 11]. This leads to endothelial dysfunction, impairing blood flow and increasing blood pressure [16]. Homocysteine also encourages the growth of smooth muscle cells in the vessel walls and decreases the production of elastic fibers, further damaging arterial health [16, 17, 10].

Through similar mechanisms, homocysteine can impair kidney function, which can further impact cardiovascular health by affecting blood pressure regulation [18, 19].

Metabolic Health

Homocysteine disrupts how your body processes insulin and controls blood sugar levels. It interferes with insulin signalling, leading to insulin resistance—a precursor to type 2 diabetes [20-24]. High homocysteine levels can also increase glucose production in the liver and reduce sugar uptake by muscles and other tissues [20, 25].

Elevated homocysteine alters how your body produces and breaks down triglycerides, leading to higher levels of unhealthy fats in your bloodstream - a key feature of metabolic syndrome.

Homocysteine can also influence how your genes work by affecting DNA methylation—a process that controls gene expression. This can have wide-ranging effects on metabolism and overall health [26, 27].

Brain Health

Elevated homocysteine levels are toxic to your brain and nervous system. High homocysteine can damage nerve cells and disrupt the protective blood-brain barrier [28]. It can overexcite brain cells, leading to cell damage or death. Homocysteine also promotes oxidative stress and triggers inflammation in the brain [28, 29].

In Alzheimer's disease, too much homocysteine helps create harmful protein buildups in the brain—hallmarks of the disease [29]. Studies have found that people with more homocysteine in their blood tend to lose their memory and thinking skills faster. They're also more likely to develop dementia [31]. The good news is that lowering homocysteine levels might slow down brain shrinkage in areas affected by Alzheimer's [32].

Homocysteine also affects stroke risk. People with high levels are more likely to have a stroke [33, 34]. If they do have a stroke, it tends to be more severe, and they often have a harder time recovering.

Interestingly, high homocysteine is linked to brain problems even when other common risk factors like high blood fats, high blood pressure or diabetes aren't present.

As we age, our bodies become less efficient at using folate (vitamin B12) to make DNA building blocks. Our brains are particularly sensitive to high homocysteine levels and have limited ability to process it. The brain relies on a single enzyme to convert homocysteine to methionine, which requires vitamin B12 to function [35].

What is the conventional reference range?

The conventional reference range for homocysteine levels in the blood is:

  • Normal: 5 to 14.5 µmol/L
  • Mildly elevated: 15-30 µmol/L
  • Moderately elevated: 30-100 µmol/L
  • Severely elevated: Greater than 100 µmol/L

This range is based on population averages and is used to identify high-risk individuals, often associated with rare genetic disorders or significant nutritional deficiencies.

What is the Superpower Optimal Range for Homocysteine?

At Superpower, we recognise the significant role of homocysteine. As such, recommend a much tighter optimal range:

  • Superpower Optimal Range: 4 to 8 µmol/L

Our optimal range is informed by studies showing increased health risks above this level, reflecting a more proactive approach to long-term health maintenance.

When assessing homocysteine levels, it's important to also consider vitamin B12 and vitamin B6 levels deficiencies in these vitamins can lead to elevated homocysteine levels and contribute to the associated health risks.

Why is the Conventional Range for Homocysteine Problematic?

At Superpower we consider the conventional reference range , typically set between 5–15 μmol/L, too broad and permissive. This range was originally established to identify severe deficiencies but fails to consider the impact of long-term exposure to homocysteine levels that, while considered "normal," contribute to chronic diseases over time.

Research has shown that even homocysteine levels at the higher end of the conventional range (~15μmol/L) can silently damage blood vessels, nerves, and bones. Elevated homocysteine leads to the formation of abnormal proteins that lose their normal function and gain harmful properties, contributing to inflammation, blood clots, and nerve damage [36, 37]. This means that individuals with homocysteine levels deemed "normal" may still be at increased risk for cardiovascular diseases, cognitive decline, and brittle bones, and cancer.

Studies have demonstrated a strong link between homocysteine levels and inflammation [1]. Higher homocysteine levels correlate with increased inflammatory markers like C-reactive protein and fibrinogen [38, 39, 7]. A large study involving over 11,000 adults found that individuals with elevated homocysteine had significantly higher levels of these inflammatory markers, independent of other risk factors [10, 40]. Chronic inflammation can accelerate the development of atherosclerosis, leading to heart attacks and strokes.

Lastly, the risk of death from all causes increases by 33.6% for each 5 µmol/L increase in homocysteine levels [38, 41].

This suggests that the upper limits of the conventional range are not sufficiently protective, nor is the range low enough to prevent chronic conditions effectively [38, 42].

Supporting Evidence from Research Studies

Extensive research supports maintaining homocysteine levels between 4-8 μmol/L. This revised range is grounded in studies demonstrating that homocysteine levels considered "normal" can have detrimental effects.

Elevated homocysteine levels have a direct impact on cardiovascular health. For every 5 μmol/L increase in homocysteine, there is a 0.5–1.2 mmHg rise in blood pressure—a key predictor of heart attacks and strokes [15]. Studies show that reducing homocysteine levels by 25% can decrease the risk of heart disease by 10% and stroke by 20%.

In fact, an increase of just 5 μmol/L in homocysteine raises the risk of coronary artery disease as much as a 20 mg/dL increase in cholesterol levels [43]!

These findings suggest that even moderate elevations within the conventional "normal" range substantially increase cardiovascular risk.

Even mildly elevated homocysteine contributes to chronic inflammation and oxidative stress, damaging blood vessel cells and increasing the risk of cardiovascular diseases.

High-normal homocysteine levels are also linked to cognitive decline, Alzheimer's disease, and dementia. The decline in brain health has been linked to increased oxidative stress and inflammation in the brain [38]. Notably, cognitive impairment caused by elevated homocysteine has been shown to improve with vitamin B supplementation, suggesting a direct link between lower homocysteine levels and brain health [44, 45].

The Rotterdam Study revealed that elevated homocysteine levels, even within the normal range, weaken bones and increase fracture risk in older adults by interfering with collagen formation[46 - 48]. Similarly, higher homocysteine levels within the normal range are associated with more severe chronic kidney disease[49 - 51].

Lastly, homocysteine levels above 11 μmol/L significantly increase the risk of death from all causes, with a drastic rise in risk observed above 15.5 μmol/L, warranting a revision of the current cut-off values [38, 41, 49, 50].

The Key Takeaway

Elevated homocysteine levels, even within conventionally "normal" ranges, pose significant risks to cardiovascular health, brain function, bone strength, and overall well-being. At Superpower, we distinguish between levels that are merely acceptable and those that are truly optimal for health and longevity.

Our recommended optimal range for homocysteine is set at 4–8 μmol/L, based on emerging clinical research that supports a narrower and lower range than conventional standards. This lower range aligns with the understanding that oxidative stress and increased inflammation are underlying factors in many chronic diseases. Maintaining homocysteine levels within this range is associated with reduced inflammation, a lower risk of cardiovascular disease, improved cognitive function, stronger bones, and decreased all-cause mortality.

References

  1. Borowska, Magdalena et al. “The Effect of Homocysteine on the Secretion of Il-1β, Il-6, Il-10, Il-12 and RANTES by Peripheral Blood Mononuclear Cells-An In Vitro Study.” Molecules (Basel, Switzerland) vol. 26,21 6671. 4 Nov. 2021, doi:10.3390/molecules26216671
  2. Alkhoury, K et al. “Chronic homocysteine exposure upregulates endothelial adhesion molecules and mediates leukocyte: endothelial cell interactions under flow conditions.” European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery vol. 41,3 (2011): 429-35. doi:10.1016/j.ejvs.2010.11.012
  3. Starkebaum, G, and J M Harlan. “Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.” The Journal of clinical investigation vol. 77,4 (1986): 1370-6. doi:10.1172/JCI112442
  4. Loscalzo, J. “The oxidant stress of hyperhomocyst(e)inemia.” The Journal of clinical investigation vol. 98,1 (1996): 5-7. doi:10.1172/JCI118776
  5. Lusis, A J. “Atherosclerosis.” Nature vol. 407,6801 (2000): 233-41. doi:10.1038/35025203
  6. Leblhuber, Friedrich et al. “The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota.” Nutrients vol. 13,2 361. 25 Jan. 2021, doi:10.3390/nu13020361
  7. Al-Kuraishy, Hayder M et al. “Parkinson's Disease Risk and Hyperhomocysteinemia: The Possible Link.” Cellular and molecular neurobiology vol. 43,6 (2023): 2743-2759. doi:10.1007/s10571-023-01350-8
  8. Li, Tianyu et al. “Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors.” PloS one vol. 10,9 e0138099. 14 Sep. 2015, doi:10.1371/journal.pone.0138099
  9. Schaffer, Alon et al. “Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study.” Thrombosis research vol. 134,2 (2014): 288-93.
  10. Ganguly, Paul, and Sreyoshi Fatima Alam. “Role of homocysteine in the development of cardiovascular disease.” Nutrition journal vol. 14 6. 10 Jan. 2015, doi:10.1186/1475-2891-14-6
  11. Faeh, David et al. “Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?.” Swiss medical weekly vol. 136,47-48 (2006): 745-56. doi:10.4414/smw.2006.11283
  12. Basu, Arpita et al. “Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.” Atherosclerosis vol. 236,1 (2014): 188-195. doi:10.1016/j.atherosclerosis.2014.07.001
  13. Okura, Takafumi et al. “Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males.” Scientific reports vol. 4 5663. 11 Jul. 2014, doi:10.1038/srep05663
  14. Zhang, Song et al. “Association between serum homocysteine and arterial stiffness in elderly: a community-based study.” Journal of geriatric cardiology : JGC vol. 11,1 (2014): 32-8. doi:10.3969/j.issn.1671-5411.2014.01.007
  15. Lim, Unhee, and Patricia A Cassano. “Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994.” American journal of epidemiology vol. 156,12 (2002): 1105-13. doi:10.1093/aje/kwf157
  16. Pang, Xiaoming et al. “Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells.” Atherosclerosis vol. 236,1 (2014): 73-81. doi:10.1016/j.atherosclerosis.2014.06.021
  17. Steed, Mesia M, and Suresh C Tyagi. “Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.” Antioxidants & redox signaling vol. 15,7 (2011): 1927-43. doi:10.1089/ars.2010.3721
  18. Baszczuk, Aleksandra, and Zygmunt Kopczyński. “Hiperhomocysteinemia u chorych na schorzenia układu krążenia” [Hyperhomocysteinemia in patients with cardiovascular disease]. Postepy higieny i medycyny doswiadczalnej (Online) vol. 68 579-89. 2 Jan. 2014, doi:10.5604/17322693.1102340
  19. Shenoy, Vijetha et al. “Correlation of serum homocysteine levels with the severity of coronary artery disease.” Indian journal of clinical biochemistry : IJCB vol. 29,3 (2014): 339-44. doi:10.1007/s12291-013-0373-5
  20. Zhang, Xuan et al. “Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation.” Cell reportsvol. 37,2 (2021): 109821. doi:10.1016/j.celrep.2021.109821
  21. Ala, Oluwabukola A et al. “Association between insulin resistance and total plasma homocysteine levels in type 2 diabetes mellitus patients in south west Nigeria.” Diabetes & metabolic syndrome vol. 11 Suppl 2 (2017): S803-S809. doi:10.1016/j.dsx.2017.06.002
  22. Joshi, Manjunath B et al. “Elevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps.” Scientific reports vol. 6 36362. 4 Nov. 2016, doi:10.1038/srep36362
  23. Meigs, J B et al. “Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.” Diabetes care vol. 24,8 (2001): 1403-10. doi:10.2337/diacare.24.8.1403
  24. Yang, Ning et al. “Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism.” PloS one vol. 10,5 e0125922. 4 May. 2015, doi:10.1371/journal.pone.0125922
  25. Kumar, Avinash et al. “The metabolism and significance of homocysteine in nutrition and health.” Nutrition & metabolism vol. 14 78. 22 Dec. 2017, doi:10.1186/s12986-017-0233-z
  26. Wang, Wen-Ming, and Hong-Zhong Jin. “Homocysteine: A Potential Common Route for Cardiovascular Risk and DNA Methylation in Psoriasis.” Chinese medical journal vol. 130,16 (2017): 1980-1986. doi:10.4103/0366-6999.211895
  27. Mandaviya, Pooja R et al. “Homocysteine and DNA methylation: a review of animal and human literature.” Molecular genetics and metabolism vol. 113,4 (2014): 243-52. doi:10.1016/j.ymgme.2014.10.006
  28. Tawfik, Amany et al. “Homocysteine and Age-Related Central Nervous System Diseases: Role of Inflammation.” International journal of molecular sciences vol. 22,12 6259. 10 Jun. 2021, doi:10.3390/ijms22126259
  29. Moretti, Rita, and Paola Caruso. “The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice.” International journal of molecular sciences vol. 20,1 231. 8 Jan. 2019, doi:10.3390/ijms20010231
  30. Oner, Pinar et al. “High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term.” Journal of personalized medicine vol. 13,3 503. 10 Mar. 2023, doi:10.3390/jpm13030503
  31. Luzzi, Simona et al. “Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art.” Biomedicines vol. 10,11 2741. 28 Oct. 2022, doi:10.3390/biomedicines10112741
  32. Smith, A David et al. “Homocysteine and Dementia: An International Consensus Statement.” Journal of Alzheimer's disease : JAD vol. 62,2 (2018): 561-570. doi:10.3233/JAD-171042
  33. Pinzon, Rizaldy Taslim et al. “The role of homocysteine levels as a risk factor of ischemic stroke events: a systematic review and meta-analysis.” Frontiers in neurology vol. 14 1144584. 12 May. 2023, doi:10.3389/fneur.2023.1144584
  34. Lehotský, Ján et al. “Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance.” Frontiers in neuroscience vol. 10 538. 23 Nov. 2016, doi:10.3389/fnins.2016.00538
  35. [BRAIN NOTE] Vallance, Patrick. “Homocysteine in Health and Disease.” Journal of the Royal Society of Medicinevol. 95,3 (2002): 159.
  36. Jakubowski, Hieronim. “Homocysteine Modification in Protein Structure/Function and Human Disease.” Physiological reviews vol. 99,1 (2019): 555-604. doi:10.1152/physrev.00003.2018
  37. McCully, Kilmer S. “Homocysteine, vitamins, and vascular disease prevention.” The American journal of clinical nutrition vol. 86,5 (2007): 1563S-8S. doi:10.1093/ajcn/86.5.1563S.
  38. Smith, A D, and H Refsum. “Homocysteine - from disease biomarker to disease prevention.” Journal of internal medicine vol. 290,4 (2021): 826-854. doi:10.1111/joim.13279
  39. Park, Chan Seok et al. “Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.” The American journal of cardiology vol. 105,9 (2010): 1284-8. doi:10.1016/j.amjcard.2009.12.045
  40. Petelina, T I et al. Klinicheskaia laboratornaia diagnostika vol. 63,8 (2018): 471-477. doi:10.18821/0869-2084-2018-63-8-471-477
  41. Fan, Rui et al. “Association between Homocysteine Levels and All-cause Mortality: A Dose-Response Meta-Analysis of Prospective Studies.” Scientific reports vol. 7,1 4769. 6 Jul. 2017, doi:10.1038/s41598-017-05205-3
  42. Veeranna, Vikas et al. “Homocysteine and reclassification of cardiovascular disease risk.” Journal of the American College of Cardiology vol. 58,10 (2011): 1025-33. doi:10.1016/j.jacc.2011.05.028
  43. Selzman, Craig. "What Is Atherosclerosis?" Abernathy's Surgical Secrets, 7th ed., Elsevier, 2018.
  44. Guo, Jun et al. “Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.” Signal transduction and targeted therapy vol. 7,1 391. 16 Dec. 2022, doi:10.1038/s41392-022-01251-0
  45. Mitchell, E Siobhan et al. “B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline.” Neuroscience and biobehavioral reviews vol. 47 (2014): 307-20. doi:10.1016/j.neubiorev.2014.08.006
  46. Vacek, Thomas P et al. “The role of homocysteine in bone remodeling.” Clinical chemistry and laboratory medicine vol. 51,3 (2013): 579-90. doi:10.1515/cclm-2012-0605
  47. Enneman, A W et al. “The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons.” Bone vol. 63 (2014): 141-6. doi:10.1016/j.bone.2014.03.002
  48. Dai, Zhaoli, and Woon-Puay Koh. “B-vitamins and bone health--a review of the current evidence.” Nutrients vol. 7,5 3322-46. 7 May. 2015, doi:10.3390/nu7053322
  49. Mo, Tingting et al. “Genetic susceptibility, homocysteine levels, and risk of all-cause and cause-specific mortality: A prospective cohort study.” Clinica chimica acta; international journal of clinical chemistry vol. 538 (2023): 1-8. doi:10.1016/j.cca.2022.11.001
  50. Kuo, H-K et al. “Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey 1999-2002.” Journal of internal medicine vol. 258,4 (2005): 328-35. doi:10.1111/j.1365-2796.2005.01546.x
  51. Long, Yanjun, and Jing Nie. “Homocysteine in Renal Injury.” Kidney diseases (Basel, Switzerland) vol. 2,2 (2016): 80-7. doi:10.1159/000444900